Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Blocklisting Interim Review

22nd May 2008 15:54

RNS Number : 1068V
GlaxoSmithKline PLC
22 May 2008
 



BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - Ordinary Shares

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

2,490,262

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

5,000,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,143,767

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

6,346,495

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - ADS

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

2,609,136

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

10,000,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

4,202,550

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

8,406,586

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome UK Share Option Scheme

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

5,119,750

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

5,119,750

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome International Share Option Scheme

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

13,267,156

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

13,267,156

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Group Limited Share Option Scheme

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

0

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

0

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome 1999 Share Option Plan

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

1,040,000

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,040,000

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

204,242

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

40,636

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

163,606

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

275,420

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

275,420

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary Shares

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

100,000

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

100,000

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

  BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 22 May 2008

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Savings Related Share Option Scheme

Period of return:

From:

8 November 2007

To:

30 April 2008

Balance of unallotted securities under scheme(s) from previous return:

2,394,996

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

5,000,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,077,914

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

6,317,082

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRBSGDUGXDGGID

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,671.28
Change38.95